Warburg Pincus to invest up to $300 mln into Vertice Pharma

Warburg Pincus will invest up to $300 million into the newly launched Vertice Pharma, a specialty pharmaceuticals company based in both the UK and New Jersey. In addition to the financing, Don DeGolyer will join Vertice as CEO while Andrew Saik will become the company's chief financial officer. Jefferies provided financial advice to Vertice Pharma on the transaction.

DealsNorth AmericaUSBriefs